Please login to the form below

Not currently logged in
Email:
Password:

Dicerna appoints chief financial officer

Jack Green to take on the role on a permanent basis

Dicerna Jack GreenUS biopharmaceutical firm Dicerna has appointed Jack Green as its chief financial officer.

Green has been serving as the company's interim chief financial officer since January this year and will now take on the role on a permanent basis.

Dr Douglas Fambrough, Dicerna's president and chief executive, said: “I am very pleased to announce Jack as permanent CFO, as he brings to Dicerna a wealth of knowledge in finance and a strong track-record with public biotech companies.

“Since joining the company as interim CFO, Jack's strategic and business insights have added tremendous value and will be instrumental to the continued growth of Dicerna.”

Green has over 30 years of financial management experience, over twenty of which he gained in the biotechnology sector.

He has served as the chief financial officer of GTC Biotherapeutics and Verastem, as well as vice president, finance of On-Q-ity, a US biotechnology company.

Green said: “Dicerna has made great progress developing an exciting pipeline of clinical-stage oncology and rare disease product candidates as well as an emerging pipeline of DsiRNA-EX conjugate programmes for liver-targeted diseases.

“I look forward to contributing to Dicerna's success as we advance these programmes through clinical development and to working closely with the management team and board of directors.”

25th April 2016

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Complete Medical Communications (CMC)

CMC is a leading global agency dedicated to healthcare communications across the lifecycle. We combine scientific acumen, excellence in delivery...

Latest intelligence

BRIC markets
BRIC markets
Why these countries offer an opportunity for pharma despite a slowdown...
Obstetrics Virtual Journal Club: An Impetus Digital Customer Success Story
Our online solutions are not just for advisory boards - find out how one client leveraged the Impetus InSite Platform® for a virtual journal club....
Ludovic Helfgott
Novo Nordisk awakens its ‘Sleeping Beauty’
Biopharm emerges from troubled times to hit ‘solid growth’, says executive vice president Ludovic Helfgott...

Infographics